Af­ter build­ing pipelines from Glax­o­SmithK­line to Flag­ship, Paul Pe­ter Tak takes the helm at an un­der-the-radar on­colyt­ic virus play­er

Paul Pe­ter Tak has done it all: From a pro­fes­sor­ship in his na­tive Nether­lands to the head of im­munoin­flam­ma­tion R&D at Glax­o­SmithK­line, from lead­ing small …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER